913 related articles for article (PubMed ID: 19184645)
1. Nicotine chemistry, metabolism, kinetics and biomarkers.
Benowitz NL; Hukkanen J; Jacob P
Handb Exp Pharmacol; 2009; (192):29-60. PubMed ID: 19184645
[TBL] [Abstract][Full Text] [Related]
2. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
[TBL] [Abstract][Full Text] [Related]
3. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
[TBL] [Abstract][Full Text] [Related]
4. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.
Schnoll RA; Patterson F; Wileyto EP; Tyndale RF; Benowitz N; Lerman C
Pharmacol Biochem Behav; 2009 Mar; 92(1):6-11. PubMed ID: 19000709
[TBL] [Abstract][Full Text] [Related]
5. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
[TBL] [Abstract][Full Text] [Related]
6. Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers.
Fagan P; Pokhrel P; Herzog TA; Pagano IS; Franke AA; Clanton MS; Alexander LA; Trinidad DR; Sakuma KL; Johnson CA; Moolchan ET
Nicotine Tob Res; 2016 Apr; 18(4):437-46. PubMed ID: 25995160
[TBL] [Abstract][Full Text] [Related]
7. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
Benowitz NL; Zevin S; Jacob P
Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
Sellers EM; Kaplan HL; Tyndale RF
Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
[TBL] [Abstract][Full Text] [Related]
9. Levels of saliva cotinine in electronic cigarette users.
Etter JF
Addiction; 2014 May; 109(5):825-9. PubMed ID: 24401004
[TBL] [Abstract][Full Text] [Related]
10. Nicotine-mecamylamine interactions.
Zevin S; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
[TBL] [Abstract][Full Text] [Related]
12. Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches.
Claire R; Coleman T; Leonardi-Bee J; Berlin I
Addiction; 2019 Sep; 114(9):1651-1658. PubMed ID: 31106486
[TBL] [Abstract][Full Text] [Related]
13. The possible role of ammonia toxicity on the exposure, deposition, retention, and the bioavailability of nicotine during smoking.
Seeman JI; Carchman RA
Food Chem Toxicol; 2008 Jun; 46(6):1863-81. PubMed ID: 18450355
[TBL] [Abstract][Full Text] [Related]
14. Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.
Esterlis I; Cosgrove KP; Batis JC; Bois F; Stiklus SM; Perkins E; Seibyl JP; Carson RE; Staley JK
J Nucl Med; 2010 Aug; 51(8):1226-33. PubMed ID: 20660383
[TBL] [Abstract][Full Text] [Related]
15. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans.
Benowitz NL; Pérez-Stable EJ; Herrera B; Jacob P
J Natl Cancer Inst; 2002 Jan; 94(2):108-15. PubMed ID: 11792749
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and disposition kinetics of nicotine.
Hukkanen J; Jacob P; Benowitz NL
Pharmacol Rev; 2005 Mar; 57(1):79-115. PubMed ID: 15734728
[TBL] [Abstract][Full Text] [Related]
17. Nicotine absorption and dependence in unlicensed lozenges available over the counter.
Foulds J; Russell MA; Jarvis MJ; Feyerabend C
Addiction; 1998 Sep; 93(9):1427-31. PubMed ID: 9926548
[TBL] [Abstract][Full Text] [Related]
18. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application.
Levi M; Dempsey DA; Benowitz NL; Sheiner LB
J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):23-34. PubMed ID: 17206525
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay.
Ziegler UE; Kauczok J; Dietz UA; Reith HB; Schmidt K
Pharmacology; 2004 Dec; 72(4):254-9. PubMed ID: 15539886
[TBL] [Abstract][Full Text] [Related]
20. Good relationship between saliva cotinine kinetics and plasma cotinine kinetics after smoking one cigarette.
Yuki D; Kikuchi A; Miura N; Kakehi A; Onozawa M
Regul Toxicol Pharmacol; 2013 Nov; 67(2):240-5. PubMed ID: 23933006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
